Michael S Boger - Concepedia

Author

Michael S Boger

Also Known As

M BOGER, M Böger, M Sean Boger, M. Sean Boger, M.S. Boger, M.Sean Boger, Michael Boger, Michael S Boger, Michael S. Boger, Michael Sean Boger

Publications

512

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina Vanderbilt University Wake Forest University

About

Michael S Boger is an author at Medical University of South Carolina specializing in medicine, hiv, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	187
2	Health Sciences	2	2	41
3	Public Health	1	1	27
4	Clinical Nutrition	1	1	11
5	Epidemiology	1	1	11

Michael S Boger

Publications

422

Citations

H-Index

Page 1

	Year	Citations
Comparative In Vitro Efficacies of Various Catheter Lock Solutions Robert J. Sherertz, Michael S Boger, Casey A. Collins, Antimicrobial Agents and Chemotherapy	2006	111
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial Zelalem Temesgen, Charles D. Burger, Jason Baker, The Lancet Respiratory Medicine Covid-19 PandemicRespiratory InfectionInfectious Respiratory DiseasePlacebo-controlled TrialHospitalised Patients	2021	70
Highly Sensitive C-Reactive Protein, Body Mass Index, and Serum Lipids in HIV-Infected Persons Receiving Antiretroviral Therapy: A Longitudinal Study Michael S Boger, Ayumi Shintani, Leigh Anne Redhage, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	38
Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant <i>Enterococcal</i> bacteremia Shawn H. MacVane, John M. Hurst, Michael S Boger, Infectious Diseases	2016	38
The Phosphatidylinositol 3-Kinase Pathway Selectively Controls sIL-1RA Not Interleukin-1β Production in the Septic Leukocytes Chris A. Learn, Michael S Boger, Liwu Li, Journal of Biological Chemistry	2001	31
A Randomized Trial of Raltegravir Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Women with Lipohypertrophy Jordan E. Lake, Grace A. McComsey, Todd Hulgan, AIDS Patient Care and STDs Visceral Adipose TissueMetabolic DisorderAntiviral DrugObesityMetabolic Syndrome	2012	30
Measures of small-fiber neuropathy in HIV infection Michael S Boger, Todd Hulgan, David W. Haas, Autonomic Neuroscience Sexual HealthHiv InfectionNeuropathic PainNeurologyPeripheral Nerve	2012	28
Establishing an Antimicrobial Stewardship Collaborative Across a Large, Diverse Health Care System Andrea Y Logan, Julie Williamson, Emily K. Reinke, The Joint Commission Journal on Quality and Patient Safety Health SystemsAntimicrobial StewardshipHealth PolicyAntibioticsHealthcare-associated Infection	2019	27
A case of Exophiala oligosperma successfully treated with voriconazole Bassam H. Rimawi, Ramzy H. Rimawi, Meena Mirdamadi, Medical Mycology Case Reports Antifungal AgentFungal PathogenAntifungal AgentsPathogenesisLymphatic Filariasis	2013	21
Impact of a Stewardship‐Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of <i>Escherichia coli</i> Urinary Isolates to Ciprofloxacin Kristen A. O'Brien, Jingwen Zhang, Patrick D. Mauldin, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2015	17

Page 1